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The incidence of AF steadily increases with age; the prevalence in those older than 80 years is up to 15%. 2 The loss of coordinated atrial activity by AF predisposes patients to thrombus formation and, subsequently, embolic stroke. 3 Moreover, chronic AF has been associated with a 2-fold increase in the risk of premature death. 3 The demographic profile of patients undergoing coronary artery bypass graft (CABG) surgery has significantly changed in the past 2 decades as the result of an increased use of coronary stents and the aging population of developed countries. Increasingly, older patients with a greater incidence of comorbidities including valvular disease, diabetes, and impaired ventricular function are undergoing CABG. [4] [5] [6] These factors are all associated with an increased risk of AF. 7 Hence, it is imperative to understand the clinical implications of preoperative atrial fibrillation (preAF) for patients undergoing CABG. Some cohort studies have demonstrated that preAF may be an independent risk factor for poorer perioperative outcomes and reduced long-term survival. [8] [9] [10] [11] [12] However, there has only been a limited evaluation of preAF in the context of CABG surgery, and the EuroSCORE has not recognized preAF as a risk modifier. Moreover, the impact of preAF on clinical outcomes according to revascularization strategy (on-pump or off-pump CABG) remains largely unexplored.
The primary aim of this of this meta-analysis was to evaluate the impact of preAF on short-and long-term outcomes after CABG surgery. As a secondary outcome, the impact of preAF on clinical outcomes depending on revascularization strategy (on-pump vs off-pump) was explored. Our hypothesis is that preAF has a negative impact on early and late outcomes after CABG surgery.
METHODS
This systematic review and meta-analysis was conducted and presented in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 13 The study was approved by the local ethics committee.
Search Strategy and Study Selection
Electronic searches were performed with Ovid Medline, Embase, and Cochrane Central Register of Controlled Trials from their dates of inception to January 2016. The search terms ''coronary artery bypass'' OR ''CABG'' were combined with ''atrial fibrillation'' AND (''baseline OR ''pre-operative'') as key words and Medical Subject Headings terms. This was supplemented searching the reference lists by hand of key reviews and all potentially relevant studies.
Two reviewers (A.S., S.A.V.) independently screened the title and abstract of records identified in the search. Full-text publications were subsequently reviewed separately if either reviewer considered the manuscript as being potentially eligible. Disagreements regarding final study inclusion were resolved by discussion and consensus.
Eligibility Criteria
Eligible studies were those reporting on clinical outcomes of isolated CABG according to the presence or absence of baseline AF. Both randomized controlled trials and observational studies were eligible for inclusion. Noncomparative studies lacking a control group of patients without preAF were excluded. Studies presenting mixed data for different cardiac surgeries were only included if clinical outcomes for the isolated CABG cohort were separately reported. Studies reporting outcomes of patients undergoing concomitant AF surgery were excluded.
All publications were limited to those involving human subjects and written in English. Abstracts, case reports, conference presentations, editorials, and expert opinions were excluded. Studies with fewer than 100 patients in either arm were also excluded. Review articles were omitted because of potential publication bias and duplication of results. When institutions published duplicate studies with accumulating numbers of patients or increased lengths of follow-up, only the most complete reports were included for quantitative assessment. 
Data Extraction and Quality Assessment
All data were independently extracted from text, tables, and figures by 2 investigators (S.A.V. and S.B.). The final results were reviewed by the senior reviewer (A.S.). For each study, the following information was extracted: study period, institution, study design, patient characteristics and risk factors, procedural details, and clinical outcomes.
The predetermined primary endpoint was perioperative all-cause mortality, defined as death occurring within 30 days of surgery or during the same hospitalization. Secondary endpoints included perioperative morbidity (stroke, acute renal failure, myocardial infarction, wound infection, prolonged ventilation, reoperation for any cause, reoperation for bleeding, need for transfusion) and midterm survival. The definition of wound infection was inconsistent between studies; some studies reported on sternal wound infection, whereas others reported any surgical-site infection (eg, sternal and/or graft).
Study quality was assessed with the Newcastle-Ottawa Scale for cohort studies, which has established validity and is recommended by the Cochrane Collaboration. A maximum total of 9 points is possible over the areas of sample selection (0-4 points), comparability of cohorts (0-2 points), and outcome assessment (0-3 points), with a score greater than 5 indicating reasonable study quality.
Statistical Analysis
The odds ratio (OR) or hazards ratio (HR) were used as summary statistics, and reported with 95% confidence intervals (CIs). When available, multivariable adjusted or propensity-matched ratios were extracted from individual studies. Otherwise, unadjusted ratios were computed from the exposure distribution given in the papers.
Meta-analyses were performed with random-effects models (inverse-variance technique) to take into account he anticipated clinical and methodologic diversity between studies. The I 2 statistic was used to estimate the percentage of total variation across studies due to heterogeneity rather than chance, with values exceeding 50% indicative of considerable heterogeneity. Subgroup analysis was conducted to specifically examine the impact of preAF on outcomes after conventional and off-pump CABG. Sensitivity analysis by study quality was conducted, excluding studies that did not report propensity-matched or multivariable adjusted ratios. In all manuscripts that were analyzed, the groups of stratified based on the presence or absence of preAF.
Publication bias was assessed by the use of funnel plots comparing log ORs with their standard error. Egger's linear regression method 14 and Begg's rank correlation test 15 were used to detect funnel plot asymmetry, and the Trim-and-Fill method was used to explore the impact of studies potentially missing due to publication bias. 16 Statistical analysis was conducted with Review Manager Version 5.1.2 (Cochrane Collaboration, Software Update, Oxford, United Kingdom) and Comprehensive Meta-Analysis v2.2 (Biostat Inc, Englewood, NJ). All P values were 2 sided, and values < .05 were considered statistically significant.
RESULTS

Study Characteristics
A total of 1105 unique records were identified through the database and bibliographic searches. After considerable filtering, 1024 were excluded on the basis of title and abstract content. After the full text of the remaining 81 articles was screened, 12 studies met the inclusion criteria. [8] [9] [10] [11] [12] [17] [18] [19] [20] [21] [22] [23] All included studies were retrospective observational reports (Table 1) . These included data on a total of 389,998 patients who underwent CABG; 370,292 patients did not have preAF and 19,706 had preAF. The median study sample size was 5240 (range, 513-281,569). In 3 studies, outcome reporting was limited to the perioperative period. 9, 17, 19 In the remaining studies, the mean or median follow-up time ranged from 3 to 12.6 years. All included studies had a Newcastle-Ottawa Scale score of at least 5, indicating good quality. Quality assessment scores for individual studies are displayed in Table E1 . Baseline demographic characteristics and risk-factor profiles of study participants are summarized in Table 2 .
Clinical Outcomes Entire cohort. The impact of preAF on perioperative and late outcomes after isolated CABG is summarized in Table  3 . There was a statistically significant association between preAF and perioperative mortality (OR, Nine studies reported sufficient data for quantitative analysis of late mortality. 4, 8, 10, 12, 18, [20] [21] [22] [23] Analysis of pooled data from these studies indicated that preAF was independently associated with late mortality (HR, 1.74; 95% CI, 1.42-2.13; P <.001; I 2 ¼ 76%). Sensitivity analysis. Eight studies, [9] [10] [11] [12] 17, 18, 22, 23 involving a total of 381,218 patients, reported propensity-matched or adjusted ratios for the primary endpoint of perioperative 10, 19, 20 involving a total of 5322 patients, examined patients undergoing off-pump CABG surgery. Of these, 305 patients presented with preAF and 5027 did not present with preAF. A summary of the impact of preAF on early and late outcomes in this study cohort is provided in Table 6 . In subgroup analysis of patients who underwent off-pump CABG, preAF was associated with an increased risk of perioperative mortality (OR, 2.75; 95% CI, 1.35-5.59; P ¼ .005, I
2 ¼ 18%, Figure 3 ). There was a trend toward an increased incidence of acute renal failure (OR, 2.29; 95% CI, 0.98-5.35; P ¼ .06; I 2 ¼ 63%). PreAF was associated with an increased risk of late mortality (HR, 1.97; 95% CI, 1.26-3.08; P ¼ .003, I
2 ¼ 33%) after off-pump CABG. Subgroup analysis: Studies excluding Society of Thoracic Surgeons. A subgroup analysis was performed of studies excluding the large Society of Thoracic Surgeons study (Table 7) . 17 In this analysis, preAF was associated with an increased risk of perioperative mortality (OR, FIGURE 1. Meta-analysis of the association of preoperative AF with perioperative mortality after CABG (adjusted studies). SE, Standard error; IV, symptoms of heart failure at rest; CI, confidence interval; OPCABG, off-pump coronary artery bypass grafting; AF, atrial fibrillation. Table 8 . Four studies were excluded. 8, 12, 22, 23 In this analysis, preAF was associated with an increased risk of perioperative mortality (OR, 1.83; 95% CI, 1.39-2.43; P < .001), stroke (OR, 1.54; 95% CI, 1.02-2.32; P ¼ .04), acute renal failure (OR, 1.52; 95% CI, 1.20-1.93; P < .001), prolonged ventilation (OR, 1.44; 95% CI, 1.14-1.83, P ¼ .002), reoperation for bleeding (OR, 1.19; 95% CI, 1.13-1.26), and infective complications (OR, 1.42; 95% CI, 1.02-1.97; P ¼ .04). There was a clear association of preAF with late mortality (HR, 1.91; 95% CI, 1.43-2.55; P <.001). Publication bias. Both Egger's linear regression method (P ¼ .13) and Begg's rank correlation test (P ¼ .30) suggested publication bias was not an influencing factor when perioperative mortality was selected as an endpoint. Accounting for potentially missing studies using the imputed trim-and-fill method did not alter the result obtained for perioperative mortality.
DISCUSSION
The present meta-analysis demonstrated the preAF is an independent risk factor for poorer perioperative outcomes and reduced overall survival after CABG. There has been considerable debate among clinicians as to whether preAF independently predisposes patients to a poorer outcome or whether it is simply a marker of a more complex physiological milieu. Certainly, preAF is associated with age, cardiovascular comorbidities, impaired ventricular function, and critical perioperative state. 7, 11 Nevertheless, our study demonstrated an independent association between preAF and poorer perioperative outcomes. A cumulative analysis of the 13 studies demonstrated that preAF increased the risk of perioperative mortality by 64% (OR, 1.64; 95% CI, 1.29-2.09; P<.001). Even when only studies that included propensity-matched or adjusted ratios were analyzed, preAF was independently associated with a 56% increase in the risk of perioperative mortality (OR, 1.56; 95% CI, 1.21-2.03; P<.001). This is an important clinical finding particularly, given that FIGURE 2. Meta-analysis of the association of preoperative AF with perioperative mortality after on-pump CABG. SE, Standard error; IV, symptoms of heart failure at rest; CI, confidence interval; AF, atrial fibrillation.
previous cohort studies may have been underpowered to detect a clinical difference. 8, 12 After mortality, the most significant sequela of AF is the increased risk of stroke. Our analyses demonstrated that preAF increased the risk of perioperative stroke by 50% (OR, 1.50; 95% CI, 1.06-2.11; P ¼ .02). Off-pump CABG has been shown to reduce the incidence of perioperative stroke. 24 Theoretically then, an off-pump revascularization strategy may reduce the incidence of stroke in patients with preAF. Attaran and colleagues 10 performed a matched analysis which compared the outcomes of patients with and without preAF based on revascularization strategy (on-pump or off-pump). The authors demonstrated that, in patients undergoing on-pump CABG, preAF was associated with a significantly greater risk of stroke (5.4% vs 1.6%, P<.001). In contrast, in patients undergoing off-pump CABG, preAF was not associated with stroke (0% vs 0.5%, P>.99). Our analyses, however, demonstrated that preAF was associated with a greater than 3-fold increase in the risk of stroke in patients undergoing off-pump CABG (OR, 3.71; 95% CI, 2.21-6.22; P<.001). The optimal revascularization strategy for patients with preAF, therefore, remains unclear, and further prospective investigation is required. It must be noted that confounding factors may have influenced the observed outcomes. For example, the presence or absence of aortic crossclamping can influence the incidence of postoperative stroke. Unfortunately, we are unable to determine on a case-by-case basis precisely what proportion of the study population had aortic crossclamping.
PreAF also was associated with an independently increased risk of acute renal failure, prolonged ventilation, and reoperation for bleeding. Several mechanisms have been proposed to explain the association between preAF and poorer early outcomes. It has been suggested that reduced ventricular filling due to AF results in hypoperfusion of end organs such as the brain and kidneys, rendering patients susceptible to stroke and renal impairment. 12 Encouragingly, however, we found no association between preAF and perioperative myocardial infarction. Moreover, our study showed no association between preAF and the rate of bleeding or blood transfusion between the 2 groups. This is an interesting observation, given that it is probable that a greater percentage of patients in preAF were on preoperative anticoagulants. The lack of a significant difference in the rate of bleeding may reflect good clinical management of preoperative anticoagulants in patients with preAF. It may also relate to good intraoperative management of coagulopathy/bleeding.
Our study demonstrated a strong association between preAF and late mortality. A cumulative analysis of the 9 studies showed that preAF increased the risk of late 12 similarly showed an absolute survival difference of 20% after 3 years (70% vs 90%; HR, 1.49; 95% CI, 1.06-2.08; P ¼ .020).
The cause for increased late mortality in patients with preAF is multifactorial. First, preAF may predispose patients to thromboembolic or hemorrhagic events. 25 Second, long-term AF may induce tachycardia-related cardiomyopathy. 26 Third, long-term AF exacerbates congestive heart failure. 27 Finally, potentially fatal anticoagulation-related complications are more common in patients with preAF due to the high use of warfarin. 10 Given the implications of preAF on poorer perioperative and long-term outcomes, some investigators have advocated to role of adjunct strategies to treat AF. European guidelines suggest that all patients with symptomatic preAF who are undergoing cardiac surgery should be offered concomitant perioperative ablation (recommendation Class IIa, Level A 28 ). They also recognize that surgical ablation should be considered in asymptomatic patients with preAF (Class IIb, Level C). 28 Cheng and colleagues 29 performed a meta-analysis of 33 studies including 10 randomized controlled trials (RCTs) that compared the outcomes of patients who underwent concomitant AF surgery with those that did not. The authors demonstrated a greater rate of sinus rhythm in RCT and non-RCT studies compared with cardiac surgery alone, and this effect remained robust over the long term (5 years). There is evidence that patients with successful sinus restoration had improved survival who were treated but remained in AF. 30 Concomitant left atrial occlusion has also been advocated as a treatment strategy to reduce stroke and perioperative mortality in patients with preAF, but further evidence is required to validate its clinical efficacy. 30 Despite this evidence, the uptake of concomitant AF surgery has been inconsistent. An analysis of data from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (2005) (2006) (2007) (2008) (2009) (2010) showed that only 27.5% of patients undergoing CABG underwent ablation compared with 61.5% of patients undergoing mitral valve repair. 31 As discussed by La Meir and colleagues, 32 there are several reasons why concomitant ablation has not been universally adopted. First, there is a lack of large RCTs demonstrating the prognostic benefit of restoring sinus rhythm. Second, many surgeons do not believe that the additional technical complexity of AF ablation justifies the future benefits of sinus rhythm, particularly in patients who do not require an atriotomy. Overall, given the negative implications of preAF on both short-and long-term outcomes, there is a need for further investigate the impact of concomitant ablative strategy in patients with preAF undergoing CABG.
Our study has several limitations. First, all included studies were retrospective, observational reports. Second, considerable heterogeneity was detected in the analysis of several perioperative complications including mortality, stroke, prolonged ventilation, and acute renal failure. This may reflect differences in reporting standards, data collection, endpoint definitions, or perioperative management across institutions. For example, the incidence of preAF varied between studies. Although, to some degree, this reflects real variation across centers, it is likely that there were differences in screening practices across institutions. Third, due to the nature of the included studies, we could not determine the impact of the type or duration of preAF on clinical outcomes. Fourth, our analysis of off-pump CABG was limited by the small number of studies reporting clinical endpoints. Fifth, AF is associated with primary or secondary structural and physiologic derangements that can have a direct influence on outcomes after cardiac operations that would not be possible to account for in the study design of a meta-analysis. Finally, the analysis of early and late mortality was limited to an assessment of overall mortality rather than diseasespecific or event-specific mortality. Moreover, we were unable to gather sufficient data to evaluate the impact of preAF on late stroke, which is an important clinical endpoint.
In conclusion, this meta-analysis demonstrates that preAF is associated with poorer perioperative outcomes and reduced long-term survival after CABG. Our study does not prove causality, but it does suggest that there is need to evaluate the role of adjunct ablative strategies (Video 1). 
